Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GoodRx Holdings, Inc. | 34,497 | reported | 08 Jul 2025 | tx 5+151,895−17,248 |
| SOLAZYME INC | 32,000 | reported | 22 May 2017 | tx 10+224,000 |
| Kyverna Therapeutics, Inc. | 21,727 | reported | 27 May 2026 | tx 4+107,660 |
| Tectonic Therapeutic, Inc. | 17,643 | reported | 06 Jun 2023 | tx 6+93,712 |
| Corvus Pharmaceuticals, Inc. | 15,000 | reported | 12 Jun 2025 | tx 14+225,000 |
| BIOMARIN PHARMACEUTICAL INC | 7,000 | reported | 01 Aug 2025 | tx 1+7,000 |
| Guardant Health, Inc. | 2,975 | reported | 20 May 2026 | tx 167+299,447−434,411 |
| AGIOS PHARMACEUTICALS, INC. | 0 | reported | 20 May 2022 | tx 18+68,701−6,549 |
| Forty Seven, Inc. | 0 | reported | 07 Apr 2020 | tx 3+10,322−136,815 |
| GENENTECH INC | 0 | reported | 26 Mar 2009 | tx 306+403,771−680,438 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 5,093 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 20,582 | 0.00 USD | deriv |
| 20 May 2026 | SALE | Guardant Health, Inc. | 6,876 | 106.90 USD | |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 209,690 | 4.41 USD | |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 21,520 | 3.61 USD | |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 21,520 | 7.84 USD | |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 12,070 | 4.08 USD | |
| 19 Dec 2025 | SALE | Olema Pharmaceuticals, Inc. | 29,904 | 28.83 USD | |
| 19 Dec 2025 | SALE | Olema Pharmaceuticals, Inc. | 193,056 | 29.71 USD | |
| 19 Dec 2025 | SALE | Olema Pharmaceuticals, Inc. | 41,840 | 30.48 USD | |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 209,690 | 0.00 USD | deriv |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 19 Dec 2025 | EXERCISE | Olema Pharmaceuticals, Inc. | 12,070 | 0.00 USD | deriv |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 9,105 | 38.42 USD | |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 8,803 | 38.01 USD | |
| 05 Dec 2025 | SALE | Guardant Health, Inc. | 3,400 | 108.05 USD | |
| 05 Dec 2025 | SALE | Guardant Health, Inc. | 8,156 | 106.67 USD | |
| 05 Dec 2025 | SALE | Guardant Health, Inc. | 17,055 | 107.27 USD | |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 10,703 | 31.84 USD | |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 9,105 | 0.00 USD | deriv |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 10,703 | 0.00 USD | deriv |
| 05 Dec 2025 | EXERCISE | Guardant Health, Inc. | 8,803 | 0.00 USD | deriv |
| 01 Aug 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 7,000 | 0.00 USD | |
| 08 Jul 2025 | EXERCISE | GoodRx Holdings, Inc. | 17,248 | 4.74 USD |